In the Media

November 1, 2018

UBC’s Dr. Yadav Talks about Producing Bio-identical Cannabinoids in the Lab using Biosynthesis

In this video, Dr. Vikramaditya Yadav of the University of British Columbia talks about using a unique biosynthesis platform to productively produce bioidentical, high purity, high grade cannabinoids. InMed collaborates with Dr. Yadav’s laboratory in developing a proprietary biosynthesis platform.

Source: BTV

Share this post

Latest Articles

Benzinga: Pharmaceutical Cannabinoids and their Impact on Treatments for Complex Diseases

InMed’s Senior VP, Preclinical Research and Development, Dr. Eric Hsu, join the Benzinga Small Cap Conference Panel Discussion “Pharmaceutical Cannabinoids and their Impact on Treatments

October 6, 2021

The Dales Report – InMed Pharmaceuticals Positioned For Growth As Cannabinoid Supply Sales Poised For Imminent “Take Off”

Shadd Dales of The Dales Report interviews InMed CEO, Eric A. Adams, on the fast-growing synthesized cannabinoid industry and the market opportunity of rare cannabinoids.

September 22, 2021

InMed and BayMedica Host First Webinar Together Following News of Signing Definitive Agreement on Acquisition

InMed and BayMedica hosted a live webinar to talk about InMed’s acquisition of BayMedica, how it positions the company as a leader in the manufacturing

September 16, 2021